Where does Naturex Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Naturex Inc. ranks #24,853 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Naturex Inc. hold?

Naturex Inc. holds 11 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Naturex Inc.'s Innovation Score?

Naturex Inc. has an Innovation Score of 28.6 out of 100 (top 72% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Naturex Inc.'s patent grant rate increasing or decreasing?

Naturex Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Naturex Inc.'s patents?

Naturex Inc.'s patents average 13.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Naturex Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Naturex Inc.

Q: What technology areas does Naturex Inc. focus on?

Naturex Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 11 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Naturex ranks #24,853 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 8 technology areas.

#24,853
of 50,000 US assignees by volume: Top 72%
by Innovation Score (28.6/100): 13.9
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24853 · US Corporation #24,853 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,853/50,000
PHOTO-FINISH Naiad Maritime Group
CPC-NARROW A61P · 8 areas
INNOV-THIN 28.6/100
CLAIMS-RICH 13.9 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Naiad Maritime Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Spinecore · near

29
Triumph Pharmaceutic… · near

29
Escape Fitness · near

29
Naturex · this assignee

29
Zhuhai Juntian Techn… · near

29
3D Lighting Innovati… · lowest

7

What this shows Naturex's Innovation Score is 28.6/100 (top 72% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Naturex's grants concentrate

Naturex Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2015. By volume, Naturex sits between NYMI Inc. and Neptune Trading, Inc..

Naturex's three-year grant acceleration

Naturex Inc. shows 1 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

NYMI

11
Naiad Maritime Gr…

11
Nanoholdings

11
Nanophase

11
Nayya Health

11
Neone

11
Neoz Pty

11
Neptune Trading

11
Naturex ◀

11

What this shows Naturex holds 11 patents at rank #24,879, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Naturex

By rank, the assignees closest to #24,879 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Naturex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Naturex, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (29 here).

Zhuhai Juntian Electronic Technology Co., Ltd. 29 Escape Fitness Limited 29 Triumph Pharmaceuticals Inc. 29 Spinecore, Inc. 29

Naturex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 Top 72% higher than 28% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Naturex Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	9.1%
2016	1	9.1%
2018	3	27.3%
2021	4	36.4%
2022	1	9.1%
2025partial year	1	9.1%

Which technologies does Naturex Inc. patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 11

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 11

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 6

B01D - SEPARATION 1

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

C12Y - ENZYMES 1

A23G - COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF 1

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#24,853

of 50,000 tracked assignees

Innovation Score

28.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.